Wayback Machine
Nov DEC Jan
Previous capture 19 Next capture
2014 2015 2016
1 captures
19 Dec 15 - 19 Dec 15
sparklines
Close Help
Mitoglitazone and PPAR-Sparing Insulin Sensitizers

Summary

Activation of peroxisome proliferator-activated receptor (PPAR) is associated with dose-limiting side effects, such as edema and bone loss. This article describes recent efforts in the development of PPAR-sparing insulin sensitizers.

  • endocrinology
  • insulin
View Full Text